JPS60197623A - 尿アルカリ化剤組成物 - Google Patents
尿アルカリ化剤組成物Info
- Publication number
- JPS60197623A JPS60197623A JP5515984A JP5515984A JPS60197623A JP S60197623 A JPS60197623 A JP S60197623A JP 5515984 A JP5515984 A JP 5515984A JP 5515984 A JP5515984 A JP 5515984A JP S60197623 A JPS60197623 A JP S60197623A
- Authority
- JP
- Japan
- Prior art keywords
- composition
- urine
- sodium citrate
- ratio
- citric acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 97
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 82
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims abstract description 52
- 210000002700 urine Anatomy 0.000 claims abstract description 41
- 239000001509 sodium citrate Substances 0.000 claims abstract description 30
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims abstract description 30
- 239000001103 potassium chloride Substances 0.000 claims abstract description 26
- 235000011164 potassium chloride Nutrition 0.000 claims abstract description 26
- 230000003113 alkalizing effect Effects 0.000 claims description 15
- 239000003795 chemical substances by application Substances 0.000 claims description 15
- 239000007787 solid Substances 0.000 claims description 2
- -1 and 1 Chemical compound 0.000 claims 1
- 150000001720 carbohydrates Chemical class 0.000 claims 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 abstract description 14
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 abstract description 14
- 229940116269 uric acid Drugs 0.000 abstract description 14
- 239000011734 sodium Substances 0.000 abstract description 8
- 239000008280 blood Substances 0.000 abstract description 5
- 210000004369 blood Anatomy 0.000 abstract description 5
- 206010020772 Hypertension Diseases 0.000 abstract description 3
- 230000029142 excretion Effects 0.000 abstract description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 abstract description 2
- 229910052700 potassium Inorganic materials 0.000 abstract description 2
- 239000011591 potassium Substances 0.000 abstract description 2
- 230000002485 urinary effect Effects 0.000 abstract 1
- 235000015165 citric acid Nutrition 0.000 description 25
- 235000011083 sodium citrates Nutrition 0.000 description 15
- 241000700159 Rattus Species 0.000 description 13
- 229940079593 drug Drugs 0.000 description 8
- 239000003814 drug Substances 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 201000001431 Hyperuricemia Diseases 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 238000005259 measurement Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000001508 potassium citrate Substances 0.000 description 3
- 229960002635 potassium citrate Drugs 0.000 description 3
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 3
- 235000011082 potassium citrates Nutrition 0.000 description 3
- 239000005715 Fructose Substances 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000003792 electrolyte Substances 0.000 description 2
- 238000002483 medication Methods 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 208000009911 Urinary Calculi Diseases 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- 230000003355 alkalizing urine Effects 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 230000021962 pH elevation Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 229960003975 potassium Drugs 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000008085 renal dysfunction Effects 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5515984A JPS60197623A (ja) | 1984-03-21 | 1984-03-21 | 尿アルカリ化剤組成物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5515984A JPS60197623A (ja) | 1984-03-21 | 1984-03-21 | 尿アルカリ化剤組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS60197623A true JPS60197623A (ja) | 1985-10-07 |
| JPH0568449B2 JPH0568449B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1993-09-29 |
Family
ID=12990961
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP5515984A Granted JPS60197623A (ja) | 1984-03-21 | 1984-03-21 | 尿アルカリ化剤組成物 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS60197623A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109430667A (zh) * | 2018-10-19 | 2019-03-08 | 张东祥 | 一种具有降尿酸作用的组合物及固体饮料 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS58194817A (ja) * | 1982-05-06 | 1983-11-12 | アルザ・コ−ポレ−シヨン | カリウム補欠療法用組成物 |
-
1984
- 1984-03-21 JP JP5515984A patent/JPS60197623A/ja active Granted
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS58194817A (ja) * | 1982-05-06 | 1983-11-12 | アルザ・コ−ポレ−シヨン | カリウム補欠療法用組成物 |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109430667A (zh) * | 2018-10-19 | 2019-03-08 | 张东祥 | 一种具有降尿酸作用的组合物及固体饮料 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0568449B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1993-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1040532A (en) | Process for producing solid bismuth-containing pharmaceutical compositions | |
| KR100311576B1 (ko) | 경구투여용 항균성 조성물 | |
| Haldane et al. | The effect of reaction changes on human inorganic metabolism | |
| NZ220898A (en) | Pharmaceutical compositions containing calcium organic salts, calcium carbonate, and polycarboxylic acids | |
| JP4395338B2 (ja) | 抗生物質活性を有する薬学的組成物 | |
| EP0339508A1 (en) | Mouth-soluble pharmaceutical compositions containing acetylcysteine | |
| SU1009467A1 (ru) | Средство дл растворени мочевых конкрементов | |
| EP0399051B1 (en) | Polyvalent antiinflammatory agent | |
| WO2022042450A1 (zh) | 三羟甲基氨基甲烷药学可接受的盐在治疗高尿酸血症药物中的应用 | |
| US4190655A (en) | Amiloride citrate | |
| JP2811331B2 (ja) | 骨形成促進剤 | |
| JPS60197624A (ja) | 尿アルカリ化性食品組成物 | |
| Beyer et al. | The formation and excretion of acetylated sulfonamides | |
| EP0839459B1 (en) | Composition containing readily absorbable calcium and process for producing the same | |
| JPS60197623A (ja) | 尿アルカリ化剤組成物 | |
| JP2003339853A (ja) | 安定な透析用剤 | |
| JPS60105619A (ja) | 尿アルカリ化性食品組成物 | |
| CN106580938A (zh) | 一种氨丁三醇有机酸盐及其制备方法和应用 | |
| JPH0430374B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| KR100367877B1 (ko) | 구연산칼륨을 주제로 한 요로결석 치료제중 분말 및 미립제형 의 제조방법 | |
| US3055805A (en) | Process of treating acidosis with t.h.a.m. | |
| Mathew et al. | Indomethacin and cation-exchange resin in the management of pseudohypoaldosteronism | |
| EP1043022B1 (en) | Sodium ion absorption inhibitors and sodium ion excretion accelerators as preventive and therapeutic agents for diseases resulting from excessive intake of common salt | |
| CA1176984A (en) | Pharmaceutical compositions for the treatment of gastric hyperacidity, gastritis and gastroduodenal ulcers | |
| JPS59144741A (ja) | ホパンテン酸カルシウム組成物 |